Merck & Co., Inc. (MRK)
NYSE
Closed
Aug 21, 2026
Day's Range
148.5952 wk Range
77.58Overview - MRK - Merck & Co., Inc.
Key Statistics
Valuation
Enterprise Value
423.18B
P/E (Trailing)
‪122.04‬
P/E (Forward)
‪15.99‬
PEG Ratio
‪-0.93‬
Price / Sales (TTM)
‪5.65‬
Price / Book
‪8.98‬
EV / EBITDA
‪14.65‬
Profitability
Gross Margin
‪73.53%‬
Profit Margin
‪4.76%‬
Operating Margin
‪-0.24%‬
Return on Assets
‪11.86%‬
Return on Equity
‪6.96%‬
Ownership
Shares Outstanding
2.46B
Float
2.46B
Short % of Shares Outstanding
‪1.15%‬
Held by Insiders
‪0.05%‬
Held by Institutions
‪82.72%‬
Price stats
Beta
‪0.21‬
50-Day Avg
‪128.00‬
200-Day Avg
‪115.30‬
Dividends
Payout Ratio
‪268.80%‬
Frequency
Quarterly
Analyst Consensus
28 analysts
Average price target
‪$ 146.54‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MRK - Merck & Co., Inc.
Peers - MRK - Merck & Co., Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NYSE.
- MRKNYSEMerck & Co., Inc.376.36BMarket Cap+44.08%52-week change122.12P/E (Trailing)‪4.76%‬Profit Margin
- LLYNYSEEli Lilly and Company1.11TMarket Cap+44.61%52-week change42.21P/E (Trailing)‪33.52%‬Profit Margin
- JNJNYSEJohnson & Johnson651.25BMarket Cap+33.98%52-week change31.50P/E (Trailing)‪21.48%‬Profit Margin
- ABBVNYSEAbbVie Inc.468.21BMarket Cap+21.67%52-week change75.06P/E (Trailing)‪9.80%‬Profit Margin
- NVSNYSENovartis AG Sponsored ADR301.94BMarket Cap+21.29%52-week change24.00P/E (Trailing)‪22.50%‬Profit Margin
- SANNYSEBanco Santander S.A. Sponsored ADR212.65BMarket Cap+34.20%52-week change14.27P/E (Trailing)‪33.46%‬Profit Margin
- NVONYSENovo Nordisk A/S206.68BMarket Cap-20.54%52-week change11.59P/E (Trailing)‪35.34%‬Profit Margin
Profile Summary - MRK - Merck & Co., Inc.
About
Merck & Co., Inc. is a global healthcare company focused on discovering, developing, manufacturing, and commercializing prescription medicines, vaccines, biologic therapies, and animal health products. Its pharmaceutical business serves major therapeutic areas including oncology, infectious diseases, immunology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
